Technical Analysis for UNCY - Unicycive Therapeutics, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Up | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Fell Below 20 DMA | Bearish | 0.00% | |
Bollinger Band Squeeze | Range Contraction | 0.00% | |
Outside Day | Range Expansion | 0.00% | |
Crossed Above 20 DMA | Bullish | -5.48% | |
180 Bullish Setup | Bullish Swing Setup | -5.48% | |
Bollinger Band Squeeze | Range Contraction | -5.48% | |
NR7 | Range Contraction | -5.48% | |
Narrow Range Bar | Range Contraction | -5.48% | |
Inside Day | Range Contraction | -5.48% | |
Fell Below 20 DMA | Bearish | -4.83% |
Alert | Time |
---|---|
60 Minute Opening Range Breakdown | about 17 hours ago |
Down 3% | about 17 hours ago |
Up 1% | about 21 hours ago |
Bullish 180 Entry | about 22 hours ago |
Rose Above Previous Day's High | about 22 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 03/29/2024
Unicycive is a biotechnology company developing novel treatment for kidney diseases. Unicycive's lead drug, Renazorb, is a novel phosphate binding agent being developed for the treatment of hyperphosphatemia. UNI-494 is a patent protected new chemical entity in late preclinical development for the treatment of acute kidney injury
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Kidney Disease Kidney Nephrology Organ Failure Acute Kidney Injury Hyperphosphatemia Chemical Entity
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Kidney Disease Kidney Nephrology Organ Failure Acute Kidney Injury Hyperphosphatemia Chemical Entity
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 2.287 |
52 Week Low | 0.47 |
Average Volume | 349,778 |
200-Day Moving Average | 0.97 |
50-Day Moving Average | 1.28 |
20-Day Moving Average | 1.46 |
10-Day Moving Average | 1.43 |
Average True Range | 0.13 |
RSI (14) | 48.45 |
ADX | 14.91 |
+DI | 24.26 |
-DI | 21.93 |
Chandelier Exit (Long, 3 ATRs) | 1.33 |
Chandelier Exit (Short, 3 ATRs) | 1.65 |
Upper Bollinger Bands | 1.58 |
Lower Bollinger Band | 1.34 |
Percent B (%b) | 0.17 |
BandWidth | 16.48 |
MACD Line | 0.03 |
MACD Signal Line | 0.05 |
MACD Histogram | -0.0186 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 1.53 | ||||
Resistance 3 (R3) | 1.55 | 1.51 | 1.51 | ||
Resistance 2 (R2) | 1.51 | 1.48 | 1.51 | 1.50 | |
Resistance 1 (R1) | 1.45 | 1.45 | 1.43 | 1.43 | 1.49 |
Pivot Point | 1.41 | 1.41 | 1.41 | 1.41 | 1.41 |
Support 1 (S1) | 1.35 | 1.38 | 1.33 | 1.33 | 1.27 |
Support 2 (S2) | 1.31 | 1.35 | 1.31 | 1.26 | |
Support 3 (S3) | 1.25 | 1.31 | 1.26 | ||
Support 4 (S4) | 1.23 |